Portfolio
HBM Healthcare Investments holds and manages a well-balanced portfolio with high value-creation potential.
Overview as at 30 June 2024
Currency allocation of assets
Emphasis on US dollar investments
56
340
US dollar (USD)
58
Euro (EUR)
12
Renminbi (CNY)
11
Swiss franc (CHF)
9
Indian rupee (INR)
5
Other currencies (CAD, DKK, GBP, HDK, SEK)
5
#87b164
#cb2648
#8c74af
#00a4c8
#dc6c3f
#e5ae1f
#49753d
#21659a
#cab415
#423e3d
Allocation of assets
Mainly invested in private companies or in companies originating
from the private companies portfolio.
62
340
Private companies
38
Public companies
22
Public (from private) companies
21
Funds
10
Cash and cash equivalents
7
Other assets
2
#87b164
#cb2648
#8c74af
#00a4c8
#dc6c3f
#e5ae1f
#49753d
#21659a
#cab415
#423e3d
Development phase of portfolio companies
Mainly invested in revenue generating companies or in companies with products at an advanced stage of development.
69
90
Profitable
35
Products on the market
23
Preclinical
7
Phase I
12
Phase II
19
Phase III
4
#87b164
#cb2648
#8c74af
#00a4c8
#dc6c3f
#e5ae1f
#49753d
#21659a
#cab415
#423e3d
Therapeutic area of the lead product of portfolio companies
Broadly diversified areas of activity.
79
350
Others
24
Oncology
21
Central nervous system
12
Synthetic biology
12
Immunology/Inflammation
9
Digital Health
8
Orphan diseases
8
Medical technology / diagnostics
6
#87b164
#cb2648
#8c74af
#00a4c8
#dc6c3f
#e5ae1f
#49753d
#21659a
#cab415
#423e3d